Polaryx Therapeutics Inc share price logo

Polaryx Therapeutics Inc Share Price

NASDAQ: PLYX

Small Cap

$6.43

+0.91

(+16.49%)

as on

Polaryx Therapeutics Inc Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.36
    $6.47
    downward going graph

    16.64%

    Downside

    0.62%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Polaryx Therapeutics Inc share price movements today

Previous Close
$5.52
Open
$5.45
Volume
927.8K
Day's Low - High
$5.36 - $6.47

Polaryx Therapeutics Inc Historical Returns

1 Month Return
+ 99.28 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Polaryx Therapeutics Inc Stock Fundamentals & Key Indicators

Check Polaryx Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$301.1M

EPS (TTM)

-0.19

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Polaryx Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Polaryx Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Polaryx Therapeutics Inc image
Polaryx Therapeutics Inc
NA$301.1MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Polaryx Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Polaryx Therapeutics Inc Stock has increased by 55% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:55% versus previous 30 day period

Polaryx Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Income
0
0
-5
0
0
EBITDA
0
0
-5
0
0
Interest Expense
-
-
-
-
-
Depreciation
-
-
-
-
-
Income Before Tax
0
0
-5
-1
-1
Income Tax Expense
-
-
-
-
-
Net Income
0
0
-5
-1
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Polaryx Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-3
-4
EBITDA
-3
-4
Interest Expense
-
-
Depreciation
-
-
Income Before Tax
-3
-30
Income Tax Expense
-
-
Net Income
-3
-30
Net Profit Margin
0.00%
0.00%

Polaryx Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
0
-5
-1
-1
Operating Cash Flow
0
0
0
0
Investing Cash Flow
-
-
-
-
Financing Cash Flow
2
0
-
3
Change in Cash
1
0
0
2

Polaryx Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2024
Net Income
-30
Operating Cash Flow
-2
Investing Cash Flow
-
Financing Cash Flow
7
Change in Cash
4

Insights on Polaryx Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, PLYX stock has moved up by 99.3%

About Polaryx Therapeutics Inc

Polaryx Therapeutics, Inc. is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (LSDs). Its drug candidate pipeline includes PLX-200 (gemfibrozil), PLX-300 (cinnamic acid), PLX-100, and PLX-400. PLX-200 (gemfibrozil), its advanced drug candidate, is an oral small molecule for the treatment of LSDs. PLX-200 is a repurposed drug that the Company is pursuing through a 505(b)(2) regulatory pathway and is designed to be administered through a novel and proprietary oral solution. PLX-300 (cinnamic acid) is a novel, oral small molecule therapy in IND-enabling studies for the treatment of LSDs. PLX-300 is an unsaturated carboxylic acid that occurs naturally in several plants as a deaminated product of phenylalanine. PLX-100 is a preclinical stage orally administrable combination therapy comprised of its PPARa agonist, PLX-200, and vitamin A, a RXRa agonist.
OrganisationPolaryx Therapeutics Inc
HeadquartersSouth Tower, Paramus, NJ, United States, 07652
CEOMr. Alex Yang J.D., L.L.M.
E-voting on sharesClick here to vote

Key Management of Polaryx Therapeutics Inc

Name

Title

Mr. Alex Yang J.D., L.L.M.

CEO & Chair of Board

Mr. G. Michael Landis CPA

CFO & Director

Mr. Andrew John O

Chief Investment Officer

Dr. Lisa L. Bollinger M.D.

Chief Medical Officer

Dr. Shrijay Vijayan M.B.A., Ph.D.

Chief Scientific & Business Development Officer

Mr. Wuxin Zhu P.M.P., Ph.D.

Chief Chemistry, Manufacturing & Controls Officer

FAQs

What is Polaryx Therapeutics Inc share price today?

Polaryx Therapeutics Inc share price today is $6.43 as on at the close of the market. Polaryx Therapeutics Inc share today touched a day high of $6.47 and a low of $5.36.

What is the 52 week high and 52 week low for Polaryx Therapeutics Inc share?

Polaryx Therapeutics Inc share touched a 52 week high of $ on and a 52 week low of $ on . Polaryx Therapeutics Inc stock price today i.e. is closed at $6.43,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Polaryx Therapeutics Inc's market capitalisation today?

Polaryx Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Polaryx Therapeutics Inc Stock (PLYX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Polaryx Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Polaryx Therapeutics Inc Shares that will get you 0.2333 shares as per Polaryx Therapeutics Inc share price of $6.43 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Polaryx Therapeutics Inc Stock (PLYX) from India?

Indian investors can start investing in Polaryx Therapeutics Inc (PLYX) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Polaryx Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Polaryx Therapeutics Inc share’s latest price of $6.43 as on March 25, 2026 at 1:29 am IST, you will get 1.5552 shares of Polaryx Therapeutics Inc. Learn more about fractional shares .